SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM

A pharmaceutical composition for delivering lorazepam in a prolonged fashion is achieved with prolonged release lorazepam pharmaceutical beads. The composition typically contains sustained release lorazepam beads and delayed sustained release lorazepam beads. The composition can provide once daily d...

Full description

Saved in:
Bibliographic Details
Main Authors Saltel, Douglas A, Vachon, Michael
Format Patent
LanguageCroatian
English
Published 19.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A pharmaceutical composition for delivering lorazepam in a prolonged fashion is achieved with prolonged release lorazepam pharmaceutical beads. The composition typically contains sustained release lorazepam beads and delayed sustained release lorazepam beads. The composition can provide once daily dosing that maintains 24 hour therapeutic effect under steady state conditions.
AbstractList A pharmaceutical composition for delivering lorazepam in a prolonged fashion is achieved with prolonged release lorazepam pharmaceutical beads. The composition typically contains sustained release lorazepam beads and delayed sustained release lorazepam beads. The composition can provide once daily dosing that maintains 24 hour therapeutic effect under steady state conditions.
Author Vachon, Michael
Saltel, Douglas A
Author_xml – fullname: Saltel, Douglas A
– fullname: Vachon, Michael
BookMark eNrjYmDJy89L5WTQDg4NDnH09HN1UQhy9XF1DHZVcPMP8g31cQzx9PcLVvB3U_DxD3KMcg1w9OVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfEeQQFGBkaGBkbGZiEhhsbEqQIAJlsoSg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMULACIJE ZADRŽANOG OTPUŠTANJA LORAZEPAMA
ExternalDocumentID HRP20210236TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP20210236TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Croatian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP20210236TT13
Notes Application Number: HR2021P000236T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210319&DB=EPODOC&CC=HR&NR=P20210236T1
ParticipantIDs epo_espacenet_HRP20210236TT1
PublicationCentury 2000
PublicationDate 20210319
PublicationDateYYYYMMDD 2021-03-19
PublicationDate_xml – month: 03
  year: 2021
  text: 20210319
  day: 19
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies Edgemont Pharmaceuticals LLC Liquidating Trust
RelatedCompanies_xml – name: Edgemont Pharmaceuticals LLC Liquidating Trust
Score 3.3274436
Snippet A pharmaceutical composition for delivering lorazepam in a prolonged fashion is achieved with prolonged release lorazepam pharmaceutical beads. The composition...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210319&DB=EPODOC&locale=&CC=HR&NR=P20210236T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFfVNq2K1SkDJiwTNYew-BEmTDVFykUOKLyXXogha2oh_39mYWp_6tgfMHjA78-3uNwNwRXjix6q6lfKqKBGg5LqUa3kplUwpanRPayZzNrIf6G6mPU3vpj14X3Fh2jih321wRNSoEvW9ac_r-foSy27_Vi5vijds-nxwUsMWO3Ss8KQFRLQnBo1CO7REyzLcWAxiI2o7FVVPESptcT-aB9qnzxNOS5n_tynOPmxHKO6jOYDe62IAu9Yq9doAdvzuxRuLnfItD-E6yZLUfAyoLcTUo2ZCBYRwfub9UoGF0BG8MDZfaGT6R3Dp0NRyJRx19rfGmRuvZ5jK6jH0Ef3XJyDkY4URjTNIVaaRe_SIcqLXTGVKRZg21ocw2iTpdHP3GezxGv9UJZMR9JvFV32OVrYpLtrd-QFsGnzR
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakDJRYI2iWn3ECRNNqSaF2kqxUvJa1EELW3Ev-_s2lpPvS07MPuA2dlvd74ZgGvCCz-W5Z2SlXmBACUzlEzPCqVgal7h9bRiXc5GDkLDG-uPk_tJA95XXBiRJ_RbJEdEiyrQ3mtxXs_Wj1iOiK1c3OZv2PX54KamIy_RscqLFhDZGZg0jpzIlm3b9BI5TMxYCFXNSBEqbfUQEwqs9DzgtJTZf5_i7sF2jOo-6n1ovM7b0LJXpdfasBMsf7yxuTS-xQHcjMaj1BqG1JES6lNrRCWEcMHY_6UCS5Er-VFivdDYCg7hyqWp7Sk46vRvjVMvWc8w7WpH0ET0Xx2DlPVVRnTOINWYTnp4I8qIUTGNqSVhet84gc4mTaebxZfQ8tLAn_rD8OkMdrmEB1h1SQea9fyrOkePW-cXYqd-AGcEf7s
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUSTAINED+RELEASE+FORMULATIONS+OF+LORAZEPAM&rft.inventor=Saltel%2C+Douglas+A&rft.inventor=Vachon%2C+Michael&rft.date=2021-03-19&rft.externalDBID=T1&rft.externalDocID=HRP20210236TT1